Nat. Biotechnol. 33, 795 (2015); published online 7 August 2015; corrected after print 6 October 2015
In the version of this article initially published, in the “Notable clinical trial results (2Q 2015)” table, clinical trial data for the drug Glembatumumab vedotin was said to be phase 3. It was phase 2, not phase 3, data. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt.3312
Rights and permissions
About this article
Cite this article
DeFrancesco, L. Erratum: Drug pipeline: 2Q15. Nat Biotechnol 33, 1109 (2015). https://doi.org/10.1038/nbt1015-1109b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1015-1109b